Kyowa Kirin Co.,Ltd.

4151 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥2,191.50
-0.66%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.24.
  • Comfortable interest cover: operating profit covers interest about 16.5 times.
  • Net profit margin is 13.5%.
  • Current assets comfortably cover current liabilities (current ratio 2.6).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Return on equity is on the lower side at 7.7%.
  • Return on capital employed is on the lower side at 6.5%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.47

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
2 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥1兆 1,474億
Current Price¥ 2,191.50
High / Low¥ 2,912.00 / 2,109.00
Stock P/E14.104132
Book Value¥ 1,174.53
Dividend Yield3.04%
ROCE6.54%
ROE7.70%
Debt to Equity0.24
Current Ratio2.60
P/B Ratio1.2524359
EPS¥ 128.07
PAT Margin13.49%
ICR16.48
Compounded Sales Growth
10 Years
5 Years 8.98%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years 6.38%
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year 7.70%
Educational data only. Not a recommendation to buy, sell or hold any security.